Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by skyhigh123on May 04, 2018 11:36am
173 Views
Post# 27982935

RE:RE:RE:RE:The List

RE:RE:RE:RE:The List These are just my thoughts. Once PBI-4050 and others from this group of drugs becomes main stream plus also the PPPS system gets approved it will become one of the most innovative R&D Biotech Company with game changing blockbuster technology. Yes there’s a little pumping going on in this answer but the the clinical results don’t lie . Most likely a IPF deal / finish the Plasminogen BLA  / PRV  / start and finish the IVIG BLA / Just these three items will change Prometic drastically. 
Imho sky 
Bullboard Posts